NCT01013324 - Study of XL147 (SAR245408) in Advanced or Recurrent Endometrial Carcinoma | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 31, 2010

Primary Completion Date

March 31, 2013

Study Completion Date

March 31, 2013

Conditions

Endometrial CancerEndometrial Neoplasms

Interventions

DRUG

XL147 (SAR245408)

dosed as capsules taken orally daily

Trial Locations (13)

Investigational Site Number 3218, Wilrijk

Investigational Site Number 3211, Leuven

Investigational Site Number 3212, Kortrijk

Investigational Site Number 1132, Abington

Investigational Site Number 1134, Philadelphia

Investigational Site Number 1239, Augusta

Investigational Site Number 1532, Orlando

Investigational Site Number 1325, Columbus

Investigational Site Number 1434, Oklahoma City

Investigational Site Number 1527, Dallas

Investigational Site Number 1526, Newport Beach

Investigational Site Number 1133, Boston

Investigational Site Number 1142, Providence